Exane Derivatives’s Pathward Financial CASH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$88.1K Sell
2,279
-267
-10% -$11.4K 0.05% 272
2022
Q1
$140K Buy
2,546
+2,385
+1,481% +$135K 0.04% 417
2021
Q4
$9.61K Sell
161
-1,265
-89% -$75.6K ﹤0.01% 592
2021
Q3
$74.8K Sell
1,426
-426
-23% -$21.2K 0.02% 575
2021
Q2
$92.2K Buy
+1,852
New +$91.9K 0.02% 549

Other funds holding CASH

Exane Derivatives's CASH Position: Q2 2022 in Review

Exane Derivatives reduced its Pathward Financial (CASH) stake by 10% in Q2 2022, selling an estimated $11.4K and leaving 2,279 shares worth $88.1K. The position accounts for 0.05% of the portfolio, ranked #272.

Exane Derivatives first reported a position in CASH in Q2 2021 and has held it in 5 quarters since. The position peaked at $140K in Q1 2022. 192 funds tracked by Wall St. Rank hold CASH as of Q2 2022.

  • Exane Derivatives held 2,279 shares of Pathward Financial worth $88.1K as of Q2 2022.
  • Exane Derivatives sold 267 Pathward Financial shares in Q2 2022, an estimated $11.4K.
  • Pathward Financial made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #272 holding.
  • Exane Derivatives first reported a position in Pathward Financial in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Pathward Financial position peaked at $140K in Q1 2022.
  • 192 funds tracked by Wall St. Rank held Pathward Financial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.